Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Semaglutide for Sale > weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - large image1
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image1
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image2
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image3
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image4
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image5
weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price buy - image6

weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price

TDS 421 Inquiries

Unit Price: Get Latest Price
CAS No.:

910463-68-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

MingHeng

Packaging:

5/10/15/20/30mg/vial,10vial/box

Sample Available:

Yes

Price valid (until):

2026-02-28

Company Type:
Trader
Location:
China
Payment Terms:
L/C,O/A,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Agrochemicals,Chemical Pesticides,Peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail   


    Sales manager:Lucy
    whatsapp:+85298463449
    Email:lucy@xtmingheng.com

     

    Buy 10 boxes of t30 and get a box of t30 for free
    Buy 5 boxes of t60 and get a box of t30 for free
    Buy 10 boxes of t60 and get a box of t60 for free


    Wholesale Price 10mg 20mg 30mg Tirzepatide Weight Loss CAS: 2023788-19-2

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 1

    Tirzepatide     is a peptide-based medication that has garnered significant attention in the field of diabetes management. As a member of the glucagon-like peptide-1 (GLP-1) receptor agonist class, Tirzepatide offers a novel approach to addressing the complexities of type 2 diabetes mellitus (T2DM). This peptide-based therapy has demonstrated promising results in clinical trials,  showcasing its potential to revolutionize diabetes treatment.

      The therapeutic potential of Tirzepatide extends beyond glycemic control, with emerging evidence suggesting its utility in addressing comorbidities commonly associated with T2DM.  Preclinical studies have indicated potential benefits of Tirzepatide in preserving beta-cell function, reducing inflammation, and improving cardiovascular function, highlighting its broader impact on metabolic health. These findings underscore the transformative role of peptide-based therapies like Tirzepatide in reshaping the landscape of diabetes care.

      In clinical practice,  Tirzepatide 10mg is typically administered via subcutaneous injection once weekly,  allowing for sustained pharmacological activity and consistent glucose-lowering effects throughout the treatment period. The recommended starting dose and titration schedule may vary based on individual patient factors, including baseline glycemic control, renal function, and concomitant medications. Close monitoring of glycemic parameters and adherence to treatment guidelines are essential to optimize therapeutic outcomes and minimize the risk of adverse events.


    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 2

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 3

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 4


    Items Specifications

    Product Name

    Tirzepatide

    Tirzepatide

    2023788-19-2

    Purity

    99%

    Molecular Weight

    4813.527g/mol

    Molecular Formula

    C225H348N48O68

    Application

    Weight loss

    Appearance

    White Lyophilized powder


      Product Function  


    The addition of GIP which anatagonizes the central effects of GLP-1 to cause nausea is designed to improve tolerability and also allow for more aggressive dosing with increased systemic exposure. A recent post-hoc analysis showed significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM

      The weight-reducing actions of the GIPR-GLP1R co-agonist tirzepatide.Considerable interest is focused on the mechanisms of action of tirzepatide, a highly effective GIPR-GLP1R co-agonist that produces superior reductions in HbA1c and body weight, relative to that achieved with 1 mg once weekly of semaglutide in people with T2D. The GIPR is expressed in multiple regions of the mouse and human brain, in subsets of neurons and glial cells, with some hypothalamic and hindbrain cells exhibiting co-expression of the GIPR and GLP1R. Chemogenetic activation of GIPR + cells in the mouse hypothalamus acutely reduced food intake; however, co-administration of exendin-4 did not produce an additive reduction of food intake when compared to either intervention alone.

      Therapy with tirzepatide, 5-15 mg once weekly produces 8-12% body weight reduction in people with T2D, prompting ongoing development of tirzepatide as a weight loss agent for people with overweight or obesity. The importance of GIP for the weight loss properties of tirzepatide in humans is uncertain; however, tirzepatide failed to reduce body weight in Glp1r−/- mice, implicating a dominant role for the GLP1R in the weight loss observed with this agent. Glucose-dependent insulinotropic polypeptide (GIP) has been shown to reduce the extent of aversive responses induced by GLP-1 in mice and rats and decrease nausea and vomiting in the shrew.

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 5


    Product Application


    •                                                              1.Helps slow food leaving your stomach
    •                                                              2.Helps prevent your liver from making too much sugar
    •                                                              3.Helps the pancreas produce more insul when your blood sugar levels are high
    •                                                              4.Can help control blood glucose
    •                                                              5.Can reduce hyperglycemia, especially after meals
    •                                                              6.Can reduce fasting insul and fasting glucose
    •                                                              7.Can reduce hemoglobin A1c
    •                                                              8.Can decrease appetite and caloric intake, while inhibiting weight gain
    •                                                              9.Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 6
    • Peptide Storage Guidelines: General Tips

      When storing peptides, remember to: • Store peptide in a cold, dry, dark place • Avoid repeated freezing and thawing of peptide • Avoid overexposure to the air
      • Avoid light exposure • Avoid storing peptides in solution long term • Aliquot peptide according to experimental requirements

    • Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 7


      Company Profile  


    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 8

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 9

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 10



      Why choose us?


    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 11


      Transportation details  


    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 12

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 13

    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 14


      Customer feedback


    Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 15 Shop weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price-Detailed Image 16

    ECHEMI Editorial Reference

    Semaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.

    Certificates
    • weight loss/reduce blood sugar| new glucagon-like peptide-1 receptor, Tirzepatide hypoglycemic, preferential price Certificates 1 TDS

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    EC Number:

    203-405-2

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Critical Temperature & Pressure:

    Store at -20°C

    Research
    Class:

    GLP-1R agonist

    Status:

    FDA-approved (Ozempic / Wegovy / Rybelsus)

    Mechanism:

    Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.

    Activity note:

    Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).

    Source:

    Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI

    Clinical Development:

    NCT03548935; NCT03552757; NCT01720446; NCT02692716

    FDA:

    Ozempic, Wegovy, Rybelsus (approved 2017-12-05)

    References
    ChEMBL:

    CHEMBL2108724

    DrugBank:

    DB13928

    KEGG DRUG:

    D10025

    PubChem:

    PubChem

    Disclaimer:

    Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Agrochemicals,Chemical Pesticides,Peptides

    Location:

    haikou

    Payment Terms:

    L/C,O/A,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2024

    Company Certificates
    • Haikou Minghengcoa coa
    Company Profile


    High-Quality Peptides: Our company specializes in premium-grade peptides, ensuring the highest standards of purity and efficacy. Each product undergoes rigorous testing to guarantee superior quality and performance.
    Cutting-Edge Technology: We leverage the latest advancements in peptide synthesis and production technology. Our state-of-the-art facilities and innovative processes enable us to deliver peptides with exceptional precision and consistency.
    Custom Solutions: We offer tailored peptide solutions to meet the specific needs of our clients. Whether you require bespoke formulations or custom quantities, our experienced team is dedicated to providing personalized support and solutions.
    Extensive Expertise: With years of experience in the peptide industry, our team of experts is well-versed in the complexities of peptide development and applications. We are committed to providing insightful guidance and technical support to help you achieve your goals.
    Comprehensive Product Range : Our diverse portfolio of peptide products covers a wide range of applications, including research, pharmaceutical development, and cosmetic formulations. This allows us to cater to various industries and meet different customer needs.

  • Inquiry History
    421 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Semaglutide

    1 G Oct 27, 2026
    Belgium

    Semaglutide

    1 MT Oct 19, 2026
    Chile

    Semaglutide

    10 MG Oct 16, 2026
    Slovakia

    semaglutide

    10 MG Oct 15, 2026
    Germany

    Semaglutide

    1 G Oct 14, 2026
    South Africa

    Semaglutide

    10 MT Oct 11, 2026
    United States

    Semaglutide

    1000 MT Oct 6, 2026
    United States

    Semaglutide

    10 MT Sep 30, 2026
    United States

    Semaglutide

    1000 KG Sep 30, 2026
    United States

    Semaglutide

    30 MG Sep 28, 2026
    United States

    Semaglutide

    10 MT Sep 25, 2026
    Philippines

    Semaglutide

    10 MG Sep 20, 2026
    India

    Semaglutide

    10 MG Sep 18, 2026
    United Kingdom

    Semaglutide - Reta - Tirz

    100 MG Sep 17, 2026
    United Kingdom

    Semaglutide

    10 G Sep 17, 2026
    United Kingdom

    Retatruide

    1 MT Sep 15, 2026
    United Kingdom

    IGF-1 LR3

    10 MT Aug 28, 2026
    Paraguay

    Semaglutide Freeze-dried Vial

    1 KG Aug 27, 2026
    United States

    Semaglutide

    2 MT Aug 25, 2026
    United States

    Semaglutide

    1 MT Aug 24, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.